State Street SPDR S&P Biotech ETF
 
 
 
 
基本資料
種類: ETF
費用比率%: 0.35
資產淨值: 126.42
成立日期: 31/01/2006
 
分析
市值分佈:
65.29%
大市值
29.87%
中市值
7.17%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 07/03/2026 05:54) 總持有投資項目: 145  
0%
 
100%
     10大 (16.71%)
代號 名稱 佔比% 持有日期
ALTAltimmune0.1827/02/2026
FDMT4D Molecular Therapeutics0.1727/02/2026
ANNXAnnexon0.1627/02/2026
VSTMVerastem0.1527/02/2026
LXEOLexeo Therapeutics0.1527/02/2026
EBSEmergent BioSolutions Inc.0.1527/02/2026
PRTAProthena Corp0.1527/02/2026
AVXLAnavex Life Sciences Corp0.1427/02/2026
MYGNMyriad Genetics0.1427/02/2026
AVBPArriVent BioPharma0.1427/02/2026
AKBAAkebia Therapeutics0.1427/02/2026
IMRXImmuneering Corp0.1427/02/2026
INBXInhibrx Biosciences Inc.0.1327/02/2026
ABSIAbsci Corp0.1227/02/2026
ABUSArbutus Biopharma Corp0.1127/02/2026
SVRASavara0.1127/02/2026
RGNXREGENXBIO0.1127/02/2026
TYRATyra Biosciences0.1127/02/2026
IVVDInvivyd0.1027/02/2026
RZLTRezolute0.0927/02/2026
  1    2    3    4    5    6   7    8  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.